skin-diseases-and-microbiology-2016_posters-abstracts

5 / 18

Volume 4, Issue 7(Suppl) J Infect Dis Ther 2016
ISSN: 2332-0877, JIDT an open access journal
Page 50
Notes:
Skin Diseases & Microbiology 2016
October 03-05, 2016
conferenceseries.com
October 03-05, 2016 Vancouver, Canada
International Conference on
Infectious Diseases, Diagnostic Microbiology &
Dermatologists Summit on Skin Infections
Personalized medicine: Regulation of genes in human skin ageing
Danial Khorsandi
Harvard Medical School, USA
As people grow older, the common conditions and developments that happen by aging is skin changes. For example, over period
of time the skin becomes drier and thin and other changes will start to occur such as appearing spots, decreasing elasticity,
increasing stiffening and appearance of wrinkles on skin. There are many medical procedures which can be helpful to mitigate skin
changing process. The most of the commercialized cosmetic products have been created for the majority of customer’s population.
For instance, the use of many anti-aging creams may or may not prevent or even treat the changes of skin. Therefore, the effect
of these products can be different on each human body reaction. The causes of this difference can be related to many parameters
such as environment, nutrition and etc. Therefore, the human genome book can be the best source of finding the most accurate
solution. The appropriate type of cream for an individual’s skin type can be verified and used accordingly. Global gene expression
profiling (commonly called genomics) is an approach that can be used in the identification of compounds for inclusion in cosmetic
formulations that improve the appearance of aged skin. In this study, the evaluations of all genes and their related antioxidants which
lead to skin aging have been studied. The main goal is to match the appropriate medical procedure with the correct type of cream.
Biography
Danial Khorsandi is currently a Researcher at the Harvard-MIT’s Division of Health Science and Technology (HST), Brigham and Women’s Hospital and Harvard Medical
School and has been working on Genomics, Biotechnology and Biomaterials for 4 years. He has worked at the Barcelona Skin Genomics company in Spain and Biomaterial
innovation research center in Boston, USA.
Danial Khorsandi, J Infect Dis Ther 2016, 4:7(Suppl)